Genpact files to sell 10M shares of common stock for holders
Selling shareholders included entities affiliated with Bain Capital Investors and its co-investor, GIC Private Limited. The selling shareholders are offering approximately 27% of Genpact's shares they beneficially own. After giving effect to this offering, the selling shareholders will beneficially own approximately 15% of Genpact's outstanding common shares. In addition, after giving effect to this offering, the number of directors that Bain Capital and its co-investors will be entitled to designate for nomination to Genpact's board of directors will be reduced to one under Genpact's shareholder agreement with the selling shareholders, which provides that Bain Capital and its co-investors have the right to designate for nomination four directors to Genpact's board of directors, subject to reduction based on certain minimum shareholding thresholds and other requirements and increases in certain circumstances. Citigroup is acting as the sole underwriter for the offering.